Background/Objectives A small number of case-control studies have suggested that mitochondrial haplogroups could be associated with obesity. We examined whether obesity risk was influenced by mitochondrial haplogroup in a large North American cohort across an 8-year period. We conducted a longitudinal cohort study including individuals from the Osteoarthritis Initiative. Subjects/Methods Mitochondrial haplogroups were determined by sequencing and PCR-RFLP techniques using this nomenclature: HV, JT, KU, IWX, and super HV/others. The strength of the association between mitochondrial haplogroups and incident obesity was quantified with hazard ratios (HRs), adjusted for potential confounders using a Cox's regression analysis. Results Overall, 2342 non-obese Caucasian participants (56.7% women) with a mean ± SD age of 62.0 ± 9.5 years at baseline were included. During a median follow-up of 8 years, 334 individuals ( = 14.3% of baseline population) became obese. After adjusting for nine potential confounders, the haplogroups IWX carried a significant 48% higher risk of obesity (HR = 1.48; 95% CI: 1.02-2.39) compared to the HV haplotype (the most frequent type). Conclusion Only the presence of the IWX haplogroups appears to be linked to increased obesity risk, independent of potential baseline confounders. Future cohort studies are needed to confirm these findings and to determine potential underlying mechanisms.
Introduction
The mitochondrial genome is a circular set of about 17,000 base pairs encoding 37 genes in human beings. Of them, 13 are translated in proteins that are involved in a diverse range of processes relevant to cellular function and survival, e.g., electron transport and oxidative phosphorylation [1] . Mitochondrial DNA (mtDNA) often undergoes pathological changes and is reported that repair mechanisms are less efficient than nuclear DNA [1, 2] . In addition, the mtDNA evolves much more quickly than average nuclear DNA. Therefore, accumulating sequentially along radiating maternal lineages [3] . Mitochondrial haplogroups are defined as specific groups of single-nucleotide polymorphisms (SNPs) which result from mismatches, and it has been increasingly recognized that different mitochondrial haplogroups may influence propensity to several chronic disease states [4] [5] [6] .
Mitochondria are essential in energy metabolism, and thus mitochondrial dysfunction could affect obesity [7] .
However, the literature regarding the possible association between mitochondrial haplogroups and obesity is still limited to a small number of case-control studies. In 2286 Caucasians of Northern European origin living in the USA, Yang et al. [8] found that haplogroup X, mt4823 and mt8873 were related to lower body mass index (BMI) and decreased body fat mass. Similarly, in an Italian study including 500 obese cases vs. 216 controls, obese people demonstrated greater frequency of haplogroup T and reduced frequency of haplogroup J compared to healthy controls [9] . Finally, in another more recent case-control study involving 1251 obese people vs. 861 normal weight individuals, haplogroup T was found to be more frequent in obese people [10] .
While these studies have advanced our knowledge regarding the possible association between mitochondrial haplogroups and obesity, a number of limitations persists. First, they all rely on a case-control study design, thus their nature does not allow the authors to infer a cause-effect direction. Second, these studies did not control for any possible confounders (e.g., physical activity or educational level or the presence of other co-morbidities), and it is possible that residual confounding exists.
As little or no longitudinal research has investigated the influence of mitochondrial haplogroups on incident obesity, and some previous case-control studies have reported insignificant associations between mitochondrial haplogroups and obesity [11] , we sought to determine whether obesity risk was linked to different mitochondrial haplogroups in a large prospective cohort of North American people.
Methods

Data source and participants
Data used in this study were obtained from the Osteoarthritis Initiative (OAI) (http://www.oai.ucsf.edu), a large ongoing nationwide study sponsored by the National Institute of Health. Data was based on patients recruited between February 2004 and May 2006 from the following four clinical sites in the US with a high risk of knee osteoarthritis. Specific data used in the current study were: baseline and screening evaluations (V00; November 2008), and assessments until the final (96 months) available evaluation (V01, V03, V05, V06, V08, V10). Written informed consent provided by all subjects.
Exposure
Haplogroup assignment was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and sequencing methods using established methods [12] . The latter consisted of the multiplex assignment of the six main SNPs that contribute to the generation of the most prevalent Caucasian haplogroups [13] (H, V, super HV, U, K, T, J) following the single base extension assay.
In line with OAI nomenclature, haplogroups were as follows: H, U, K, J, T, V, super HV, I, W, X, or others. We consequently clustered these haplogroups following the classification suggested by MITOMAP and followed by another study assessing mitochondrial haplogroups and cardiovascular disease [14, 15] into HV, JT, KU, IWX, and super HV/others.
Outcomes
In the OAI, a trained nurse measured weight and height with standardized methods. Weight was recorded without shoes, heavy jewellery, or wallets, and in lightweight clothing in kg. Height was measured without shoes, using the required breathing technique during each measurement. Two initial measurements were made, with the participant a step away from the stadiometer, then step back into the measurement position. If the difference between these two measurements was >4 mm, other two measurements were made. Height was initially recorded in mm. BMI ≥ 30 kg/m 2 in agreement with the guidelines suggested by the World Health Organization (WHO) [16] was used for the definition of obesity 2 . These measures were repeated at each visit, i.e., V01, V03, V05, V06, V08, and V10.
Covariates
Obesity risk across mitochondrial haplogroups was examined after controlling for the following potential confounders (1) baseline BMI; (2) physical activity, using physical activity scale for elderly (PASE) [17] , which assesses 12 different physical activities (e.g., walking, housework). It is scored on a 0-400 scale and has been validated in older populations; (3) smoking habits (previous/current vs. never); (4) education (degree vs. lower levels); (5) annual income ( ≥ $50,000 vs. < $50,000 or missing data); (6) co-morbidities, quantified with the modified Charlson scale (higher scores indicate greater severity); and (7) total energy intake (in daily kcal) assessed with a semi-quantitative food frequency questionnaire [18] .
Statistical analyses
Means and standard deviations (continuous outcomes) and count percentage (categorical outcomes) were computed for mitochondrial haplogroups, with analysis of variance (ANOVA) and Pearson's chi-square used as corresponding inferential tests. Normality was assessed with the Kolmogorov-Smirnov test. We used Levene's test to assess equality of variance, with Welch's ANOVA used in the event of any violation of this assumption. Post-hoc analyses were run and Bonferroni adjustments were applied. The haplotype HV (the most common) was used as the reference group in all comparisons.
Proportional hazards (Cox) regression was used to quantify the magnitude of the association of mitochondrial haplogroups and incident obesity, with an outcome of time to the onset of obesity or to the last observation made. All the analyses excluded individuals with obesity at baseline. Participant attrition due to death was censored at the date of death.
Factors associated with obesity at follow-up in the univariable analysis were included in the model. A VIF (variance inflation factor) of ≥2 was used as a threshold for multicollinearity, but no variable was excluded for this reason. The baseline model was adjusted for age and sex, while the fully adjusted model also controlled for baseline BMI, education, smoking, income, co-morbidity, physical activity, and daily energy intake (see previous section for how these variables were categorized). Hazard ratios (HRs) with 95% confidence intervals (CIs) were used as the primary outcome statistic.
Analyses were conducted with SPSS 17.0, with using p < 0.05 used to indicate significance.
Results
Participants
Haplogroup data was not available for 1047 of 4796 participants with data from a further 126 excluded due to technical problems. Moreover, 1167 people were already obese at baseline, whilst other 114 were lost at follow-up. Therefore, the final sample of the current study consisted of 2342 eligible individuals (Fig. 1) .
Baseline analyses
The 2342 participants included had a mean age of 62.0 ± 9.5 (45-79) years, with slightly more women ( = 56.7%). All the participants included were Caucasian and the mean ± SD BMI at baseline was 25.6 ± 2.7 kg/m 
Association between mitochondrial haplogroups and incident obesity
After a median period of 8 years, 334 individuals (14.3% of baseline population) developed obesity. As shown in Table 2 , the incidence of obesity was higher in people with the haplotype IWX (31; 95% CI: 20-48 per 1000 persons-year) and others/super HV haplogroups (35; 95% CI: 25-50 per 1000 persons-year) compared to the reference group, HV (22; 95% CI: 18-25 per 1000 personsyear) (Fig. 1) .
Using a Cox's regression analysis, adjusted for nine demographic and clinical potential confounders and taking people with the HV haplotype as reference, the haplogroup IWX carried a significantly higher risk for obesity by about 48% (HR = 1.48; 95% CI: 1.02-2.39) ( Table 2) .
Discussion
To the best of our knowledge, the current study is the first longitudinal investigation of the relationship between mitochondrial haplogroups and obesity. We found that over a follow-up period of 8 years, people who had an IWX haplotype (n = 100; = 4.2% of the baseline population) were approximately 48% more likely to develop obesity compared to the most frequent haplotype (HV). This finding remained significant even when accounting for several potential confounders assessed at baseline which are known to influence the risk of obesity, such as physical activity and education status.
It is noteworthy that at baseline, participants with the IWX haplotype did not have any significant difference in potential risk factors for obesity, in particular baseline BMI. However, after 8 years of follow-up, the IWX haplogroup carried a sizeable and consistent increase of nearly 50% in obesity incidence, suggesting an important role of these haplotypes for this condition. In contrast to previous literature regarding this topic, haplogroup T was not linked to obesity. However, in the most recent study regarding the possible association between mitochondrial haplogroups and obesity, the relationship between haplogroup T and juvenile obesity disappeared after adjustment for multiple testing [10] . Several reasons can explain the differences between our study and those reporting a significant association between haplogroup T and obesity. First, we used a different categorization of mitochondrial haplogroups compared to the case-control studies mentioned and consequently a different reference group. In particular, we grouped the group T with the J as suggested by MITOMAP and in agreement with other works suggesting that mitochondrial haplogroup J and T form a cluster with shared polymorphisms (e.g., mtDNA T4216C) and were formerly described as sister haplogroups with a common root [19] . Second, the design of our study (longitudinal vs. case-control) may lead to different results.
The precise reason why the IWX haplogroup is linked to obesity is unclear and clearly warrants investigation. One potential reason may be that participants of these haplogroups may have had lower energy expenditure and higher fat accumulation. In a study including 231 subjects suffering from AIDS, the ten people of haplogroup I exhibited higher baseline extremity fat compared to other haplogroups, while those in haplogroup W had the greatest increase in extremity fat over 96 months of follow-up [20] . However, other studies are needed to confirm these findings coming from a special population. Our findings are of importance since obesity is increasing worldwide. As recently as 2010, 3.4 million deaths were linked to obesity, as well as nearly 4% of disability-adjusted life-years worldwide [21] . While there are clearly substantive environmental contributions to obesity, genetic components are also likely to contribute with heritability estimates of 40-70% suggested [22] . Obesity is a multifactorial disease due to an interaction between environmental and genetic factors. Among genetic factors, Genome-Wide Association Studies (GWAS) suggested that a core network module in humans and mice is possible. This network module is rich of genes involved in the inflammatory and immune response and probably play a role for obesity-related traits [23] . For a long time, it was discussed if a person may become obese for a low energy expenditure or for a too high energy intake with diet [24] . Low energy expenditure is traditionally seen as risk factor for obesity. In industrialized countries, it is common for half of a waking day sitting and the other half consisting of low volume physical activity [25] . Recent studies suggest that the low energy expenditure resulting from this low level of activity may have a significant direct relationship with obesity [26] . However, more recent studies proposed that high energy intake may have a more important role than low energy expenditure in determining obesity [27] . The role of genetic factors in determining obesity is very conflicting and still debated. As shown by several studies [28, 29] , most people probably have some genetic predisposition to obesity, but the movement from genetic predisposition to obesity itself requires a strong interaction with other environmental factors, such as diet and lifestyle [30] .
However, contrary to the literature regarding nuclear DNA [31, 32, 33] the literature regarding mitochondrial haplogroups is still limited, but could be of importance since the sequencing of the complete mtDNA genome is now readily available, and in the coming era of personalized medicine, these types of genetic discoveries may integrate these information into clinical practice, for tailored therapeutic intervention strategies [34] .
It is important to note that these findings should be treated cautiously. First, data were only available for Caucasians and thus cannot be automatically generalised to outside of this specific ethnic group. Second, the OAI study included only people with or at high risk of knee osteoarthritis, and so the same concerns about generalisability to wider population must apply. These limitations notwithstanding, the large cohort included at baseline, the control for a number of important confounders and the long-followup period, make an important contribution to our understanding of how genetic haplotype may confer a vulnerability to obesity.
In conclusion, in our study, mitochondrial haplogroups IWX carried a significant higher risk of obesity compared to the most frequent haplogroups, HV. Future longitudinal studies in general population are, however, needed to confirm/refute our findings.
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